185
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Effect of low dose of berberine on the radioresistance of cervical cancer cells via a PI3K/HIF-1 pathway under nutrient-deprived conditions

, , , , & ORCID Icon
Pages 1060-1067 | Received 13 Jul 2019, Accepted 08 May 2020, Published online: 08 Jun 2020
 

Abstract

Purpose: Radiotherapy (RT) is one of the major treatments of cervical cancer. Although the prognosis of clinical cervical cancer becomes better in recent years, some patients still suffer from the recurrence and metastasis. Insufficiency of glucose and oxygen supply could increase the radioresistance of cervical cancer cells through regulating hypoxia-inducible factor 1 (HIF-1) in tumor microenvironment and glucose metabolism. And, berberine can regulate HIF-1. However, how berberine regulates tumor microenvironment and radioresistance through HIF-1 remains to be elucidated.

Materials and methods: The human HeLa cervical cancer cells were treated with berberine and radiation under the high and low concentrations of glucose and oxygen, respectively. The survival of cells was tested by CCK-8 assay and colony formation assay. We investigated the PI3K- and IDH3α-related pathway molecules that may regulate HIF-1α by qPCR and western blot. Differentially expressed genes (DEGs) were identified by integrating five related cohort profile datasets. Protein–protein interaction (PPI) network analyses of DEGs related to HIF-1α were conducted by using the STRING database and Cytoscape software.

Results: Berberine dramatically damaged HeLa cells under hypoxic and low-glucose conditions compared with the normoxic and high-glucose conditions. The clonogenic assay indicated that the application of berberine decreased the number of colony counts compared to the negative control. Low doses of berberine might decrease the level of phospho-PI3K and HIF-1α under the nutrient-deprived conditions. Moreover, we found that most of the differentially expressed genes which were related to CDKN1B were the downstream molecules regulated by HIF-1α.

Conclusion: The results indicated that berberine could dramatically overcome the low-glucose and hypoxia-induced radioresistance. And the regulation berberine on nutrition-deficient conditions might involve in PI3K/HIF-1 pathway. Thus, the interference of glucose metabolism by berberine might be an attractive method to eliminate radioresistant cells and improve radiotherapy efficacy.

Disclosure statement

The authors declare no conflict of interest.

Additional information

Funding

This study was supported by the Medical Scientific Research Project, Chongqing Health and Family Planning Commission, China [Grant no. 20141003]. Chongqing Clinical Oncological Research Center, the Chongqing Science and Technology Commission (CSTC), China [Grant no. cstc2015yfpt_gcj-syjzx120010]. And the Natural Science Foundation of Chongqing, the Chongqing Science and Technology Commission (CSTC), China [Grant no. cstc2018jcyjAX0012].

Notes on contributors

Xiaozhu Zeng

Xiaozhu Zeng, is a master degree candidate at Chongqing Medical University from 2018 until 2021, Chongqing, China. She performed the experiments, analyzed and integrated of data and wrote the manuscript. She is now focusing on basic research in oncology.

Linghong Wan

Linghong Wan, is a master degree candidate at Chongqing Medical University from 2017 until 2020, Chongqing, China. She carried out acquisition of data. She is now mainly studying clinical research in oncology.

Yu Wang

Yu Wang, MD, PhD is a clinical doctor of Pediatrics at the Southwest Hospital, Army Medical University, Chongqing, China. She facilitated quality assurance of data. Her research interest is hyperoxia damage.

Jinmin Xue

Jinmin Xue, is a master degree candidate at Chongqing Medical University from 2017 until 2020, Chongqing, China. She conducted a part of cell experiments. She is familiar with clinical research in radiation oncology.

Huaju Yang

Huaju Yang, is a master degree candidate at Chongqing Medical University from 2017 until 2020, Chongqing, China. She is involved in bioinformatics analysis. She focuses clinical research in oncology.

Yuxi Zhu

Yuxi Zhu, MD, PhD is a radio-oncologist of the First Affiliated Hospital of Chongqing Medical University, Chongqing, China. He not only designed the study, and also fulfill the initial manuscript and critically revised the final manuscript. His research interest is radioresistance and hypoxia.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,004.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.